Spectral appoints new board member

17-Aug-2009 - Canada

Spectral Diagnostics Inc. announced the appointment of Dr. Michael Cross to the Company's Board of Directors. Dr. Cross is Vice President of Investments at GrowthWorks Capital

Dr. Cross brings more than 20 years of life sciences, venture capital and biotechnology industry experience to the Spectral Board. At GrowthWorks, he is responsible for identifying private and public equity investment opportunities in the life sciences area and he serves on the boards of a number of public and private life sciences companies. Prior to joining GrowthWorks, Dr. Cross has held senior management positions at MDS Proteomics, MDS Capital and Viventia Biotech.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances